B cell-derived transforming growth factor-[beta]1 expression limits the induction phase of autoimmune neuroinflammation
Studies in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), have shown that regulatory B cells modulate the course of the disease via the production of suppressive cytokines. While data indicate a role for transforming growth factor (TGF)-β1 expression in r...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2016-10, Vol.6, p.34594 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 34594 |
container_title | Scientific reports |
container_volume | 6 |
creator | Bjarnadóttir, Kristbjörg Benkhoucha, Mahdia Merkler, Doron Weber, Martin S Payne, Natalie L Bernard, Claude C A Molnarfi, Nicolas Lalive, Patrice H |
description | Studies in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), have shown that regulatory B cells modulate the course of the disease via the production of suppressive cytokines. While data indicate a role for transforming growth factor (TGF)-β1 expression in regulatory B cell functions, this mechanism has not yet been tested in autoimmune neuroinflammation. Transgenic mice deficient for TGF-β1 expression in B cells (B-TGF-β1-/- ) were tested in EAE induced by recombinant mouse myelin oligodendrocyte glycoprotein (rmMOG). In this model, B-TGF-β1-/- mice showed an earlier onset of neurologic impairment compared to their littermate controls. Exacerbated EAE susceptibility in B-TGF-β1-/- mice was associated with augmented CNS T helper (Th)1/17 responses. Moreover, selective B cell TGF-β1-deficiency increased the frequencies and activation of myeloid dendritic cells, potent professional antigen-presenting cells (APCs), suggesting that B cell-derived TGF-β1 can constrain Th1/17 responses through inhibition of APC activity. Collectively our data suggest that B cells can down-regulate the function of APCs, and in turn encephalitogenic Th1/17 responses, via TGF-β1, findings that may be relevant to B cell-targeted therapies. |
doi_str_mv | 10.1038/srep34594 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1899099423</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1899099423</sourcerecordid><originalsourceid>FETCH-proquest_journals_18990994233</originalsourceid><addsrcrecordid>eNqNis1KAzEURoMgWLQL3-BC16OTn4FmW1F8AHciJc7cdFLyM96bWB_fFnwAz-aD8x0h7mX_IHu9fWTCRZvBmiuxUr0ZOqWVuhFr5mN_ZlDWSLsSpx2MGGM3IYVvnKCSy-wLpZAPcKByqjN4N9ZC3fsnVvchAX8WQuZQMsSQQmWoM0LIUxvrRS6zY4TiwbVaQkotI2RsVEL20aXkLtWduPYuMq7_9lZsXp7fnl67hcpXQ677Y2mUz9debq3trTVK6_9Vvx2kU1s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899099423</pqid></control><display><type>article</type><title>B cell-derived transforming growth factor-[beta]1 expression limits the induction phase of autoimmune neuroinflammation</title><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Bjarnadóttir, Kristbjörg ; Benkhoucha, Mahdia ; Merkler, Doron ; Weber, Martin S ; Payne, Natalie L ; Bernard, Claude C A ; Molnarfi, Nicolas ; Lalive, Patrice H</creator><creatorcontrib>Bjarnadóttir, Kristbjörg ; Benkhoucha, Mahdia ; Merkler, Doron ; Weber, Martin S ; Payne, Natalie L ; Bernard, Claude C A ; Molnarfi, Nicolas ; Lalive, Patrice H</creatorcontrib><description>Studies in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), have shown that regulatory B cells modulate the course of the disease via the production of suppressive cytokines. While data indicate a role for transforming growth factor (TGF)-β1 expression in regulatory B cell functions, this mechanism has not yet been tested in autoimmune neuroinflammation. Transgenic mice deficient for TGF-β1 expression in B cells (B-TGF-β1-/- ) were tested in EAE induced by recombinant mouse myelin oligodendrocyte glycoprotein (rmMOG). In this model, B-TGF-β1-/- mice showed an earlier onset of neurologic impairment compared to their littermate controls. Exacerbated EAE susceptibility in B-TGF-β1-/- mice was associated with augmented CNS T helper (Th)1/17 responses. Moreover, selective B cell TGF-β1-deficiency increased the frequencies and activation of myeloid dendritic cells, potent professional antigen-presenting cells (APCs), suggesting that B cell-derived TGF-β1 can constrain Th1/17 responses through inhibition of APC activity. Collectively our data suggest that B cells can down-regulate the function of APCs, and in turn encephalitogenic Th1/17 responses, via TGF-β1, findings that may be relevant to B cell-targeted therapies.</description><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep34594</identifier><language>eng</language><publisher>London: Nature Publishing Group</publisher><subject>Animal models ; Antigen-presenting cells ; Cell activation ; Central nervous system ; Cytokines ; Dendritic cells ; Experimental allergic encephalomyelitis ; Growth factors ; Inflammation ; Lymphocytes B ; Lymphocytes T ; Multiple sclerosis ; Myelin ; Oligodendrocyte-myelin glycoprotein ; Rodents ; T cell receptors ; Transforming growth factor-b1 ; Transgenic mice</subject><ispartof>Scientific reports, 2016-10, Vol.6, p.34594</ispartof><rights>Copyright Nature Publishing Group Oct 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Bjarnadóttir, Kristbjörg</creatorcontrib><creatorcontrib>Benkhoucha, Mahdia</creatorcontrib><creatorcontrib>Merkler, Doron</creatorcontrib><creatorcontrib>Weber, Martin S</creatorcontrib><creatorcontrib>Payne, Natalie L</creatorcontrib><creatorcontrib>Bernard, Claude C A</creatorcontrib><creatorcontrib>Molnarfi, Nicolas</creatorcontrib><creatorcontrib>Lalive, Patrice H</creatorcontrib><title>B cell-derived transforming growth factor-[beta]1 expression limits the induction phase of autoimmune neuroinflammation</title><title>Scientific reports</title><description>Studies in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), have shown that regulatory B cells modulate the course of the disease via the production of suppressive cytokines. While data indicate a role for transforming growth factor (TGF)-β1 expression in regulatory B cell functions, this mechanism has not yet been tested in autoimmune neuroinflammation. Transgenic mice deficient for TGF-β1 expression in B cells (B-TGF-β1-/- ) were tested in EAE induced by recombinant mouse myelin oligodendrocyte glycoprotein (rmMOG). In this model, B-TGF-β1-/- mice showed an earlier onset of neurologic impairment compared to their littermate controls. Exacerbated EAE susceptibility in B-TGF-β1-/- mice was associated with augmented CNS T helper (Th)1/17 responses. Moreover, selective B cell TGF-β1-deficiency increased the frequencies and activation of myeloid dendritic cells, potent professional antigen-presenting cells (APCs), suggesting that B cell-derived TGF-β1 can constrain Th1/17 responses through inhibition of APC activity. Collectively our data suggest that B cells can down-regulate the function of APCs, and in turn encephalitogenic Th1/17 responses, via TGF-β1, findings that may be relevant to B cell-targeted therapies.</description><subject>Animal models</subject><subject>Antigen-presenting cells</subject><subject>Cell activation</subject><subject>Central nervous system</subject><subject>Cytokines</subject><subject>Dendritic cells</subject><subject>Experimental allergic encephalomyelitis</subject><subject>Growth factors</subject><subject>Inflammation</subject><subject>Lymphocytes B</subject><subject>Lymphocytes T</subject><subject>Multiple sclerosis</subject><subject>Myelin</subject><subject>Oligodendrocyte-myelin glycoprotein</subject><subject>Rodents</subject><subject>T cell receptors</subject><subject>Transforming growth factor-b1</subject><subject>Transgenic mice</subject><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNis1KAzEURoMgWLQL3-BC16OTn4FmW1F8AHciJc7cdFLyM96bWB_fFnwAz-aD8x0h7mX_IHu9fWTCRZvBmiuxUr0ZOqWVuhFr5mN_ZlDWSLsSpx2MGGM3IYVvnKCSy-wLpZAPcKByqjN4N9ZC3fsnVvchAX8WQuZQMsSQQmWoM0LIUxvrRS6zY4TiwbVaQkotI2RsVEL20aXkLtWduPYuMq7_9lZsXp7fnl67hcpXQ677Y2mUz9debq3trTVK6_9Vvx2kU1s</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Bjarnadóttir, Kristbjörg</creator><creator>Benkhoucha, Mahdia</creator><creator>Merkler, Doron</creator><creator>Weber, Martin S</creator><creator>Payne, Natalie L</creator><creator>Bernard, Claude C A</creator><creator>Molnarfi, Nicolas</creator><creator>Lalive, Patrice H</creator><general>Nature Publishing Group</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20161001</creationdate><title>B cell-derived transforming growth factor-[beta]1 expression limits the induction phase of autoimmune neuroinflammation</title><author>Bjarnadóttir, Kristbjörg ; Benkhoucha, Mahdia ; Merkler, Doron ; Weber, Martin S ; Payne, Natalie L ; Bernard, Claude C A ; Molnarfi, Nicolas ; Lalive, Patrice H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_18990994233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animal models</topic><topic>Antigen-presenting cells</topic><topic>Cell activation</topic><topic>Central nervous system</topic><topic>Cytokines</topic><topic>Dendritic cells</topic><topic>Experimental allergic encephalomyelitis</topic><topic>Growth factors</topic><topic>Inflammation</topic><topic>Lymphocytes B</topic><topic>Lymphocytes T</topic><topic>Multiple sclerosis</topic><topic>Myelin</topic><topic>Oligodendrocyte-myelin glycoprotein</topic><topic>Rodents</topic><topic>T cell receptors</topic><topic>Transforming growth factor-b1</topic><topic>Transgenic mice</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bjarnadóttir, Kristbjörg</creatorcontrib><creatorcontrib>Benkhoucha, Mahdia</creatorcontrib><creatorcontrib>Merkler, Doron</creatorcontrib><creatorcontrib>Weber, Martin S</creatorcontrib><creatorcontrib>Payne, Natalie L</creatorcontrib><creatorcontrib>Bernard, Claude C A</creatorcontrib><creatorcontrib>Molnarfi, Nicolas</creatorcontrib><creatorcontrib>Lalive, Patrice H</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bjarnadóttir, Kristbjörg</au><au>Benkhoucha, Mahdia</au><au>Merkler, Doron</au><au>Weber, Martin S</au><au>Payne, Natalie L</au><au>Bernard, Claude C A</au><au>Molnarfi, Nicolas</au><au>Lalive, Patrice H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>B cell-derived transforming growth factor-[beta]1 expression limits the induction phase of autoimmune neuroinflammation</atitle><jtitle>Scientific reports</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>6</volume><spage>34594</spage><pages>34594-</pages><eissn>2045-2322</eissn><abstract>Studies in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), have shown that regulatory B cells modulate the course of the disease via the production of suppressive cytokines. While data indicate a role for transforming growth factor (TGF)-β1 expression in regulatory B cell functions, this mechanism has not yet been tested in autoimmune neuroinflammation. Transgenic mice deficient for TGF-β1 expression in B cells (B-TGF-β1-/- ) were tested in EAE induced by recombinant mouse myelin oligodendrocyte glycoprotein (rmMOG). In this model, B-TGF-β1-/- mice showed an earlier onset of neurologic impairment compared to their littermate controls. Exacerbated EAE susceptibility in B-TGF-β1-/- mice was associated with augmented CNS T helper (Th)1/17 responses. Moreover, selective B cell TGF-β1-deficiency increased the frequencies and activation of myeloid dendritic cells, potent professional antigen-presenting cells (APCs), suggesting that B cell-derived TGF-β1 can constrain Th1/17 responses through inhibition of APC activity. Collectively our data suggest that B cells can down-regulate the function of APCs, and in turn encephalitogenic Th1/17 responses, via TGF-β1, findings that may be relevant to B cell-targeted therapies.</abstract><cop>London</cop><pub>Nature Publishing Group</pub><doi>10.1038/srep34594</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2045-2322 |
ispartof | Scientific reports, 2016-10, Vol.6, p.34594 |
issn | 2045-2322 |
language | eng |
recordid | cdi_proquest_journals_1899099423 |
source | DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Animal models Antigen-presenting cells Cell activation Central nervous system Cytokines Dendritic cells Experimental allergic encephalomyelitis Growth factors Inflammation Lymphocytes B Lymphocytes T Multiple sclerosis Myelin Oligodendrocyte-myelin glycoprotein Rodents T cell receptors Transforming growth factor-b1 Transgenic mice |
title | B cell-derived transforming growth factor-[beta]1 expression limits the induction phase of autoimmune neuroinflammation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T10%3A49%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=B%20cell-derived%20transforming%20growth%20factor-%5Bbeta%5D1%20expression%20limits%20the%20induction%20phase%20of%20autoimmune%20neuroinflammation&rft.jtitle=Scientific%20reports&rft.au=Bjarnad%C3%B3ttir,%20Kristbj%C3%B6rg&rft.date=2016-10-01&rft.volume=6&rft.spage=34594&rft.pages=34594-&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep34594&rft_dat=%3Cproquest%3E1899099423%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899099423&rft_id=info:pmid/&rfr_iscdi=true |